BioPharm America 2014 EBD Group MassBio Image Map
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2015 Press Releases

News for BioPharm America™ 2015 will be available soon.

October 2, 2014Record number of licensing opportunities presented at BioPharm America™ 2014 International Life Science Partnering Event in Boston The seventh annual BioPharm America international life science partnering conference wrapped up last week, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event was attended by close to 900 high-level delegates representing 511 companies from 38 countries who engaged in 2,343 one-to-one partnering meetings with 787 lice...  more ►

September 22, 2014FierceBiotech's 2014 "Fierce 15" Announced Today at BioPharm America™ 2014International Life Science Partnering Event in Boston
The seventh annual BioPharm America international life science partnering conference kicked off today in Boston with the live announcement of the biotech's most daring characters in biopharma, the "Fierce 15," by John Carroll, Editor-in-Chief of FierceBiotech. "It's always a lot of fun to look over a new group of Fierce 15 companies," said John Carroll, Editor-in-Chief, of ...  more ►

September 8, 2014BioPharm America™ 2014 leads off with Fierce 15 Announcement and Keynote Address featuring Chief Scientific Officer from Sanofi The seventh annual BioPharm America international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic r...  more ►

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

February 24, 2015 ORYX to expect first clinical data on three novel cancer immunotherapies Six months after introducing itself at BIO-Europe® in Frankfurt, ORYX Translational Medicine arrives at BIO-Europe Spring® in Paris ready to unveil for potential partners the first clinical results from its highly innovative cancer immunotherapy programs. more ►

February 24, 2015 Venture capitalists surfing on a wave of success In the run-up to this year’s BIO Europe Spring® in Paris, the European venture capital community is enjoying an upswing. Trade sales and IPOs fuel the capital market with new money to invest. more ►

February 24, 2015 Servier brings partner-friendly deals to truly innovative projects "The idea is to work together," said Pascal Touchon, VP for Scientific Cooperation and Business Development at Servier. "We are licensing in and licensing out products, but I don't always like these two terms. Our goal is to truly partner, to de-risk and further develop a product that will create value for patients and doctors." more ►

February 17, 2015 Nuance Biotech targets China and South Africa Nuance Biotech, a Shanghai based startup, plans to in-license China rights to development-stage drug candidates—a fairly common model. But Nuance's version of the model has a differentiating twist. As Mark Lotter, the company's Founder and CEO told ChinaBio® Today in an exclusive interview, Nuance expects to develop the drugs in both China and South Africa. more ►

February 16, 2015 Interview: Michael Yu, Innovent Biologics From day one, Innovent has defined its business model to achieve one primary goal: Be the best or leading biopharmaceutical company in China. Michael Yu of Innovent discusses how he is growing Innovent to execute on its ambitious vision. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America 2014 EBD Group MassBio Image Map